PRS24 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS FF/VI AND UMEC/VI IN PATIENTS WITH COPD- HEALTHCARE RESOURCE UTILIZATION DATA AND ASSOCIATED COSTS – GERMANY
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2418
https://www.valueinhealthjournal.com/article/S1098-3015(18)35720-6/fulltext
Title :
PRS24 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS FF/VI AND UMEC/VI IN PATIENTS WITH COPD- HEALTHCARE RESOURCE UTILIZATION DATA AND ASSOCIATED COSTS – GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35720-6&doi=10.1016/j.jval.2018.09.2418
First page :
Section Title :
Open access? :
No
Section Order :
1771